Jakob Lyngby Kjærgaard

Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial

Eklöf, J., Alispahic, I. A., Sivapalan, P., Wilcke, T., Seersholm, N., Armbruster, K., Kjærgaard, J. L., Saeed, M. I., Nielsen, T. L., Browatzki, A., Overgaard, R. H., Fenlev, C. S., Harboe, Z. B., Andreassen, H. F., Lapperre, T. S., Pedersen, L., Johnsen, S., Ulrik, C. S., Janner, J., Moberg, M. & 19 others, Heidemann, M., Weinreich, U. M., Vijdea, R., Linde, H., Titlestad, I., Johansson, S. L., Rosenvinge, F. S., Østergaard, C., Ghathian, K. S. A., Gundersen, L., Christensen, C. W., Bangsborg, Jette Marie, Jensen, T. T., Sørensen, V. M., Ellingsgaard, T., Datcu, R., Coia, J. E., Bodtger, U. & Jensen , Jens-Ulrik Stæhr , 2022, In: Trials. 23, 817.

Research output: Contribution to journal › Journal article › Research › peer-review